Invasive Carcinoma — Trials

Invasive Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

1,812 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 603
Recruiting: 301
Ph III recruiting: 36
Growth YoY: +27.2%
Industry share: 19%
Top sponsor: National Cancer Institute (NCI)
Termination share: 37.2%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (282)

clinicaltrialsPublishedShowing 401–450 of 686 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT05960578	Golimumab and Apalutamide for the Treatment of Castration-Resistant Prostate Cancer, TRAMP Study	active not recruiting	Phase 2	8	University of WashingtonOTHER	1	Apr 14, 2026	clinicaltrials
NCT06044857	PSMA PET Response Guided SabR in High Risk Pca	recruiting	Phase 1	20	University of Texas Southwestern Medical CenterOTHER	1	Apr 14, 2026	clinicaltrials